Your browser doesn't support javascript.
loading
Toward Harmonization of Voriconazole CLSI and EUCAST Breakpoints for Candida albicans Using a Validated In Vitro Pharmacokinetic/Pharmacodynamic Model.
Beredaki, Maria-Ioanna; Georgiou, Panagiota-Christina; Siopi, Maria; Kanioura, Lamprini; Andes, David; Arendrup, Maiken Cavling; Mouton, Johan W; Meletiadis, Joseph.
Affiliation
  • Beredaki MI; Clinical Microbiology Laboratory, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Georgiou PC; Clinical Microbiology Laboratory, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Siopi M; Clinical Microbiology Laboratory, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Kanioura L; Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Andes D; Department of Medicine and Microbiology and Immunology, University of Wisconsin, Madison, Wisconsin, USA.
  • Arendrup MC; Unit of Mycology, Statens Serum Institut, Copenhagen, Denmark.
  • Mouton JW; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Meletiadis J; Department of Clinical Microbiology, University of Copenhagen, Copenhagen, Denmark.
Article in En | MEDLINE | ID: mdl-32229492

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Candida albicans / Antifungal Agents Limits: Animals Language: En Journal: Antimicrob Agents Chemother Year: 2020 Type: Article Affiliation country: Greece

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Candida albicans / Antifungal Agents Limits: Animals Language: En Journal: Antimicrob Agents Chemother Year: 2020 Type: Article Affiliation country: Greece